© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
The Future of GLP-1RAs in Obesity Treatment: Expert Perspective
September 04, 2025
With the surge in demand and supply shortages, Michael Crotty, MD, discusses the future of GLP-1RA use in the treatment of obesity.
Study Links Older Age and Low Fitness to Higher Risk of Arrhythmias in Healthy Adults
September 04, 2025
Research reveals that older age and lower aerobic fitness significantly increase the risk of arrhythmias, highlighting the need for early screening and fitness maintenance.
US Counties With Low Screening See Higher Cervical Cancer Death Rates: Daily Dose
September 04, 2025
Your daily dose of the clinical news you may have missed.
GLP-1RAs for Weight Management: Weighing Benefits vs Side Effects
September 03, 2025
Obesity medicine specialist Michael Crotty, MD, discusses the benefits of GLP-1 receptor agonist use in weight management and its impact on obesity-related comorbidities.
FDA Approves Automated Insulin Delivery System for Adults With Type 2 Diabetes
September 03, 2025
FDA clears MiniMed 780G for integration with Abbott’s Instinct sensor and approves its use in insulin-requiring T2D, expanding automated insulin delivery options.
Overcoming Barriers in Obesity and Hypertension Management: Practical Strategies for Physicians
September 02, 2025
Caissa Troutman, member of the Obesity Medicine Association, emphasizes the importance of shared decision-making in overcoming barriers.
Real-World Study: Semaglutide Lowers Cardiovascular Risk More Than Tirzepatide in Adults With Obesity and CVD
September 02, 2025
At ESC 2025, the STEER study showed semaglutide reduced risk of heart attack, stroke, or death by 57% vs tirzepatide in adults with obesity and cardiovascular disease, complementing prior trial data.
FDA Approves Subcutaneous Leqembi Autoinjector for Maintenance Therapy in Early Alzheimer Disease
September 01, 2025
The FDA has cleared Eisai and Biogen’s Leqembi Iqlik, the first at-home subcutaneous autoinjector for maintenance therapy in patients with early Alzheimer disease.
Updated COVID-19 Vaccines Are Approved, But Population Restrictions Concern Experts
August 29, 2025
Seniors remain protected along with any adult or child with underlying risk factors for severe disease, but the healthy US population is left with a choice, so far.
Spotting the Subtle Signs of Depression: How Familiarity Helps Family Physicians Excel, With Teresa Lovins, MD
August 29, 2025
Primary care clinicians see a higher share of visits for depression than mental health professionals largely because they know their patients so well, Lovins said.